Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Drug insight: Clopidogrel nonresponsiveness.

Gurbel PA, Tantry US.

Nat Clin Pract Cardiovasc Med. 2006 Jul;3(7):387-95. Review.

PMID:
16810174
2.

Clopidogrel resistance?

Gurbel PA, Tantry US.

Thromb Res. 2007;120(3):311-21. Epub 2006 Nov 14. Review.

PMID:
17109936
3.

Clinical applications of antiplatelet therapy.

Wiviott SD, Tantry US, Gurbel PA; American College of Cardiology; American Heart Association.

Rev Cardiovasc Med. 2006 Summer;7(3):130-46; quiz 148-9. Review.

PMID:
17088858
4.

[Clopidogrel resistance].

Güray Y, Güray U, Korkmaz S.

Anadolu Kardiyol Derg. 2009 Jun;9(3):231-7. Review. Turkish.

PMID:
19520658
5.

Benefits and risks of clopidogrel use in patients with coronary artery disease: evidence from randomized studies and registries.

Motovska Z, Kala P.

Clin Ther. 2008;30 Pt 2:2191-202. doi: 10.1016/j.clinthera.2008.12.001. Review.

PMID:
19281914
6.

Antiplatelet treatment of cardiovascular disease: a translational research perspective.

Gurbel PA, Antonino MJ, Tantry US.

Pol Arch Med Wewn. 2008 May;118(5):289-97. Review.

7.

Contemporary use of clopidogrel in patients with coronary artery disease.

Parikh SA, Beckman JA.

Curr Cardiol Rep. 2007 Jul;9(4):257-63. Review.

PMID:
17601391
8.

Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives.

Angiolillo DJ, Fernandez-Ortiz A, Bernardo E, Alfonso F, Macaya C, Bass TA, Costa MA.

J Am Coll Cardiol. 2007 Apr 10;49(14):1505-16. Epub 2007 Mar 26. Review.

10.

Clopidogrel resistance--the cardiologist's perspective.

Fefer P, Hod H, Matetzky S.

Platelets. 2007 May;18(3):175-81. Review.

PMID:
17497429
11.

Clopidogrel and risk for acute coronary events.

Mood GR, Bhatt DL.

Curr Atheroscler Rep. 2007 Nov;9(5):401-8. Review.

PMID:
18001624
12.

Clopidogrel use in coronary heart disease and percutaneous coronary intervention.

Atiemo AD, Williams MS.

J Investig Med. 2008 Apr;56(4):689-700. doi: 10.231/JIM.0b013e31816bfa8c. Review.

PMID:
18382265
13.

Clopidogrel and aspirin in cardiovascular medicine: responders or not--current best available evidence.

Tourmousoglou CE, Rokkas CK.

Cardiovasc Hematol Agents Med Chem. 2008 Oct;6(4):312-22. Review.

PMID:
18855644
15.

Recent developments in clopidogrel pharmacology and their relation to clinical outcomes.

Gurbel PA, Antonino MJ, Tantry US.

Expert Opin Drug Metab Toxicol. 2009 Aug;5(8):989-1004. doi: 10.1517/17425250903107772. Review.

PMID:
19575629
16.

Clopidogrel nonresponsiveness in patients undergoing percutaneous coronary intervention with stenting: a systematic review and meta-analysis.

Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Jukema JW, Huisman MV.

Am Heart J. 2007 Aug;154(2):221-31. Review.

PMID:
17643570
17.

Clopidogrel resistance: myth or reality?

Barsky AA, Arora RR.

J Cardiovasc Pharmacol Ther. 2006 Mar;11(1):47-53. Review.

PMID:
16703219
18.

The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes.

Toth PP.

Postgrad Med. 2009 Jan;121(1):59-72. doi: 10.3810/pgm.2009.01.1955. Review.

PMID:
19179814
19.

Emergence of the concept of platelet reactivity monitoring of response to thienopyridines.

Bonello L, De Labriolle A, Scheinowitz M, Lemesle G, Roy P, Steinberg DH, Pinto Slottow TL, Pakala R, Pichard AD, Barragan P, Camoin-Jau L, Dignat-George F, Paganelli F, Waksman R.

Heart. 2009 Aug;95(15):1214-9. doi: 10.1136/hrt.2008.152660. Epub 2009 Feb 5. Review.

PMID:
19196732
20.

Role of clopidogrel in managing atherothrombotic cardiovascular disease.

Eshaghian S, Kaul S, Amin S, Shah PK, Diamond GA.

Ann Intern Med. 2007 Mar 20;146(6):434-41. Review.

PMID:
17371888
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk